Takeda Settles Diabetes Drug Patent Dispute
The largest drug company in Japan, Takeda Pharmaceutical Co. Ltd., has settled a patent infringement dispute with India-based generics maker Aurobindo Pharma Ltd. over Takeda's profitable diabetes drug Actoplus Met....To view the full article, register now.
Already a subscriber? Click here to view full article